Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FEED
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Christian Michael Glibert | $FEED ENvue Medical, Inc. | Sale | 210,000 | $0.69 | $144.9K Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.05 | $305 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.07 | $307 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 10 | $3.05 | $30.5 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 90 | $3.05 | $275 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.07 | $307 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.06 | $306 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 82 | $3.05 | $250 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 98 | $3.05 | $299 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 417 | $3.05 | $1,272 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 2 | $3.05 | $6.1 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 183 | $3.05 | $558 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.05 | $305 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.05 | $305 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.05 | $305 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 18 | $3.05 | $54.9 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 50 | $3.05 | $153 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 500 | $3.05 | $1,525 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 200 | $3.06 | $612 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.04 | $304 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 4 | $3.05 | $12.2 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 4 | $3.05 | $12.2 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 10 | $3.05 | $30.5 Sale | Form 4 ↗ |
| Feb 2, 2026 | Bank of America Corp /DE/ 10% owner | FEED ENvue Medical, Inc. | Sale | 100 | $3.05 | $305 Sale | Form 4 ↗ |
| Jan 14, 2026 | Christian Michael Glibert 10% owner | FEED ENvue Medical, Inc. | Buy | 240,000 | $2.67 | $640.8K Buy | Form 4 ↗ |
32 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances